Your browser doesn't support javascript.
loading
The UK Experience of a Treatment Strategy for Pediatric Metastatic Medulloblastoma Comprising Intensive Induction Chemotherapy, Hyperfractionated Accelerated Radiotherapy and Response Directed High Dose Myeloablative Chemotherapy or Maintenance Chemotherapy (Milan Strategy).
Vivekanandan, Sindu; Breene, Richard; Ramanujachar, Ramya; Traunecker, Heidi; Pizer, Barry; Gaze, Mark N; Saran, Frank; Thorp, Nicky; English, Martin; Wheeler, Kate Ah; Michalski, Antony; Walker, David A; Saunders, Daniel; Cowie, Fiona; Cameron, Alison; Picton, Susan V; Parashar, Deepak; Horan, Gail; Williams, Michael V.
Affiliation
  • Vivekanandan S; Clinical Oncology, Cambridge University Hospitals NHS Foundation Trust Addenbrooke's Hospital, Cambridge, UK.
  • Breene R; Paediatric Oncology, Cambridge University Hospitals NHS Foundation Trust Addenbrooke's Hospital, Cambridge, UK.
  • Ramanujachar R; Paediatric Oncology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Traunecker H; Paediatric Oncology, Children's Hospital for Wales, Cardiff, UK.
  • Pizer B; Paediatric Oncology, Alder Hey Children's Hospital NHS Foundation Trust, Liverpool, UK.
  • Gaze MN; Clinical Oncology, University College London Hospitals NHS Foundation Trust, London, UK.
  • Saran F; Clinical Oncology, The Royal Marsden NHS Foundation Trust, Surrey, UK.
  • Thorp N; Clinical Oncology, The Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK.
  • English M; Paediatric Oncology, Birmingham Children's Hospital NHS Foundation Trust, Birmingham, UK.
  • Wheeler KA; Paediatric Oncology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Michalski A; Paediatric Oncology, Great Ormond Street Hospital For Children NHS Foundation Trust, London, UK.
  • Walker DA; Paediatric Oncology, Nottingham Children's Hospital University of Nottingham, Nottingham, UK.
  • Saunders D; Clinical Oncology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
  • Cowie F; Clinical Oncology, Beatson West of Scotland Cancer Centre, Glasgow, UK.
  • Cameron A; Clinical Oncology, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
  • Picton SV; Paediatric Oncology, The Leeds Teaching Hospitals, Leeds, UK.
  • Parashar D; Cancer Research Unit, Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK.
  • Horan G; Clinical Oncology, Cambridge University Hospitals NHS Foundation Trust Addenbrooke's Hospital, Cambridge, UK.
  • Williams MV; Clinical Oncology, Cambridge University Hospitals NHS Foundation Trust Addenbrooke's Hospital, Cambridge, UK.
Pediatr Blood Cancer ; 62(12): 2132-9, 2015 Dec.
Article in En | MEDLINE | ID: mdl-26274622
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cerebellar Neoplasms / Medulloblastoma Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Country/Region as subject: Europa Language: En Journal: Pediatr Blood Cancer Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2015 Document type: Article Affiliation country: United kingdom Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cerebellar Neoplasms / Medulloblastoma Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Country/Region as subject: Europa Language: En Journal: Pediatr Blood Cancer Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2015 Document type: Article Affiliation country: United kingdom Country of publication: United States